Mavacoxib is a selective cyclooxygenase 2 inhibitor used as a pharmaceutical raw material in veterinary medicine. It is a pyrazole derivative containing sulfonamide and organofluorine functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 170569-88-7
Celecoxib
pharmaceutical raw material
Aprepitant
pharmaceutical raw material
Ipamorelin
pharmaceutical raw material
Doxycycline monohydrate
pharmaceutical raw material
Roblitinib
pharmaceutical raw material
CHEMBL29923
pharmaceutical raw material
4-Desmethyl-2-methyl Celecoxib
pharmaceutical intermediate
2,5-Dimethylcelecoxib
pharmaceutical raw material
4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
TTZNQDOUNXBMJV-UHFFFAOYSA-N
C1=CC(=CC=C1C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F)F